Circulating SFRP5 levels are elevated in drug‐naïve recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls

By  

DIABETES/METABOLISM: RESEARCH AND REVIEWS (ELECT), Vol. 31, Iss. 2, 2015-02 ,pp. : 212-219

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impaired glucose tolerance and endothelial damage, as assessed by levels of von Willebrand factor and circulating endothelial cells, following acute myocardial infarction

By Jessani Shahirose   Lane Deirdre   Shantsila Eduard   Watson Timothy   Millane Teri   Lip Gregory  

Annals of Medicine, Vol. 41, Iss. 8, 2009-01 ,pp. : 608-618

Informa Healthcare

Access to resources Recommend Favorite

Dietary and physical activity counselling on Type 2 diabetes and impaired glucose tolerance by physicians and nurses in primary healthcare in Finland

By Poskiparta Marita   Kasila Kirsti   Kiuru Päivi  

Scandinavian Journal of Primary Health Care, Vol. 24, Iss. 4, 2006-12 ,pp. : 206-210

Informa Healthcare

Access to resources Recommend Favorite

Alogliptin, but not voglibose, ameliorates dyslipidemia and LDL particle size in patients with impaired glucose tolerance or Type 2 diabetes

By Aramaki Masanobu  

Clinical Lipidology, Vol. 8, Iss. 5, 2013-10 ,pp. : 533-540

Future Medicine

Access to resources Recommend Favorite

Umbelliferone Improves an Impaired Glucose and Lipid Metabolism in High‐Fat Diet/Streptozotocin‐Induced Type 2 Diabetic Rats

By  

PHYTOTHERAPY RESEARCH, Vol. 29, Iss. 9, 2015-09 ,pp. : 1388-1395

John Wiley & Sons Inc

Access to resources Recommend Favorite